GeoVax Labs Faces Delisting Notice
Ticker: GOVX · Form: 8-K · Filed: Nov 18, 2024 · CIK: 832489
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: GOVX
TL;DR
GeoVax Labs got a notice about possibly being delisted. Big trouble ahead?
AI Summary
GeoVax Labs, Inc. filed an 8-K on November 18, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is based in Smyrna, Georgia, and is incorporated in Delaware.
Why It Matters
This filing indicates potential issues with GeoVax Labs' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- GeoVax Labs, Inc. (company) — Registrant
- November 18, 2024 (date) — Date of earliest event reported
- Smyrna, Georgia (location) — Company business address
- Delaware (location) — State of incorporation
FAQ
What specific listing rule or standard has GeoVax Labs failed to satisfy?
The filing does not specify the exact rule or standard that GeoVax Labs has failed to satisfy, only that a notice has been received.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 18, 2024.
What is the exact name of the registrant?
The exact name of the registrant is GeoVax Labs, Inc.
In which state is GeoVax Labs, Inc. incorporated?
GeoVax Labs, Inc. is incorporated in Delaware.
What is the business address of GeoVax Labs, Inc.?
The business address of GeoVax Labs, Inc. is 1900 Lake Park Drive, Suite 380, Smyrna, GA 30080.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-11-18 16:02:13
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share GOVX The Nasdaq Capital M
- $2,500,000 m — any that it no longer complied with the $2,500,000 minimum stockholders' equity required for
- $8,503,876 — 024, evidencing stockholders' equity of $8,503,876, the Nasdaq staff determined that the C
Filing Documents
- govx20241118_8k.htm (8-K) — 24KB
- 0001437749-24-035609.txt ( ) — 168KB
- govx-20241118.xsd (EX-101.SCH) — 4KB
- govx-20241118_def.xml (EX-101.DEF) — 13KB
- govx-20241118_lab.xml (EX-101.LAB) — 17KB
- govx-20241118_pre.xml (EX-101.PRE) — 13KB
- govx20241118_8k_htm.xml (XML) — 5KB
01
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 23, 2024, the Company received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it no longer complied with the $2,500,000 minimum stockholders' equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), because the Company's stockholders' equity as reported in its Form 10-Q for the period ended March 31, 2024 did not meet the required minimum, and as of the date of the Notice, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations (together with the Stockholders' Equity Requirement, the "Listing Rule"). On July 18, 2024, the Company received notice from Nasdaq granting its request for an extension of time to regain compliance with the Stockholders' Equity Requirement until November 19, 2024. On November 18, 2024, the Company received a notice from Nasdaq notifying the Company that, based on its Form 10-Q for the period ended September 30, 2024, evidencing stockholders' equity of $8,503,876, the Nasdaq staff determined that the Company complies with the Listing Rule and this matter is now closed. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 18, 2024 GEOVAX LABS, INC. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer